Freedom of information disclosure log

This page contains publicly available information released following a freedom of information (FOI) access request.

About the disclosure log

The APVMA is required by section 11C of the Freedom of Information Act 1982 (the FOI Act) to publish a freedom of information disclosure log on its website. The disclosure log lists information that has been released in response to FOI access requests. This requirement has applied since 1 May 2011.

The disclosure log requirement does not apply to:

  • personal information about any person if publication of that information would be ‘unreasonable’
  • information about the business, commercial, financial or professional affairs of any person if publication of that information would be ‘unreasonable’
  • other information covered by a determination made by the Australian Information Commissioner if publication of that information would be ‘unreasonable’
  • any information if it is not reasonably practicable to publish the information because of the extent of modifications that would need to be made to delete the information listed in the above dot points.

The information described in the below disclosure log table has been released by the APVMA under the FOI Act and is available for public access.

Any documents uploaded to the APVMA disclosure log may be removed after 12 months of publication.

Information that is not available online may be obtained by emailing foi@apvma.gov.au. A charge may be imposed to reimburse the APVMA for the cost incurred in copying or reproducing the information or sending it to you. There will be no charge for the time spent by the APVMA in processing the FOI request that led to this information being made available. You will be notified if any charge is payable and you will be required to pay the charge before the information is provided.

There may be documents in the disclosure log that are currently not available in HTML format. If you are unable to read the format provided please contact foi@apvma.gov.au. The APVMA will try to meet all reasonable requests for an alternate format of the document in a timely manner and at the lowest reasonable cost to you.

Disclosure log table

Note: Documents released as a result of any of the below FOI requests are available from the APVMA upon written request.

APVMA reference number

Date published

Summary of FOI request

Description of documents (released in full or in part)

LEX 4859 1 August 2016 Documents recording or evidencing the accessing by any person for any purpose between 6 August 2012 and the date of the request the composition and impurity profile of a certain active constituent. Three documents released in part.
LEX 4773 1 July 2016 Documents in relation to the permit application for the importation and use of the active constituent Fluridone, and associated communication relating to Penrith Lakes Scheme Water Bodies. Nineteen documents released in part.
LEX 4661 17 February 2016 The company name(s), the product (s) concerned and more detail regarding the compliance offences contained in the notices mentioned in your regulatory update number 220. Five documents released in part.
LEX 4630 13 January 2016 Copies of e-mails and attachments sent to/from APVMA employees to/from the following e-mail exchanges: @croplife.org.au and @croplife.org from 1 January 2014, narrowing the search to four keywords: Neonicotinoid(s), glyphosate, atrazine, chlorpyrifos. Four documents released in full.
LEX 4648 4 January 2016 A list of the products described in the APVMA’s financial report as endocrine system, anabolic steroids and sex hormones. One document released in full.
LEX 4507 1 September 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible
    reactions'
  8. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable deaths'
  9. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible deaths'

One document released in full.

The document can be accessed at: apvma.gov.au/node/15786

LEX 4443 31 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786
LEX 4431 31 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 February 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786
LEX 4423 31 August 2015 A copy of an updated report of the numbers and reactions reported to the Hendra vaccine.

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786
LEX 4473 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'
  8. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable deaths'
  9. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible deaths'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786  
LEX 4471 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786  
LEX 4470 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  4. The number of possible deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 2015
  5. The number of probably deaths reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 30 June 15
  6. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  7. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786  
LEX 4468 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 15
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786  
LEX 4442 25 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and  9 February 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 9 Feb 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 15 and 9 February 15
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786  
LEX 4465 18 August 2015
  1. The total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  2. The number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  3. The number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January 2015 and 1 June 2015
  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'probable reactions'
  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with 'possible reactions'
  6. Information regarding my own horse’s case
Five documents released in full.
LEX 4389 10 August 2015 The numbers of reactions to the Equivac Hev vaccine currently being administered under Permits number 14887 and prior Permits 13510 and 14876 reported to the APVMA, and the break-up of those reactions into ‘APVMA Categories’, i.e. ‘Probable’, ‘Possible’ etc.

One document released in full.

 

The document can be accessed at: apvma.gov.au/node/15786
LEX 4294 6 August 2015
  1. the total number of reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014 and between 1 January and 9 February 2015

  2. the number of probable reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014, and between 1 January 2015 and 9 February 2015

  3. the number of possible reactions reported in relation to the Hendra vaccine for the years 2012, 2013, 2014, and between 1 January 2015 and 9 February 2015

  4. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with ‘probable reactions’

  5. A BRIO extract listing the APVMA’s prescribed clinical symptoms associated with ‘possible reactions’

Three documents released in full
LEX 4119 24 November 2014
  1. any submission made by any third party in relation to the APVMA's invitation (pursuant to section 13 of the Agricultural and Veterinary Chemicals Code Act 1994) for submissions in relation to Startect, dated 12 August 2014 (which expired on 12 September) titled 'Public release summary' (Invitation); and
  2. any communication or information received by the APVMA from a third party in relation to the Invitation.
This request is pursuant to the Agricultural and Veterinary Chemicals Code Act 1994 (specifically section 8W(1)) and Freedom of Information Act 1982.
Two submissions released. One in full, one in part.

G11233

29 August 2014

Scientific evidence that demonstrates the efficacy of certain APVMA registered pool sanitisers in respect of the 2014 APVMA guidelines.

Documents do not exist.
Decision

G10968

6 May 2014

Correspondence between the APVMA and Fruit West between 1 January 2012 and 1 January 2014.

Emails, letters and notices released in part.

G10953

14 April 2014

Adverse experience report prepared by Intervet Australia Pty Ltd (trading as MSD Animal Health) received by the APVMA in 2012 and related correspondence regarding AnguiMonas vaccine (PER12623).

Adverse experience report and correspondence released in part.

G10783

3 December 2013

Information concerning trials for Tri-solfen (60099).

Dose determination study on a topical local anaesthetic preparation for use in sheep, field study to evaluate the safety and efficacy of a topical local anaesthetic spray for use in sheep, and safety evaluation on a topical local anaesthetic preparation for use in sheep released in part.

G10489

16 October 2013

Unfiltered data (copies of all adverse experience forms marked ‘Lack of effect/poor efficacy’) lodged between 1 January and 31 December 2010 by veterinarians, pet owners and manufacturers for CPV-2 antigen-containing vaccines administered to dogs of all ages.

Adverse experience reports submitted to the APVMA relating to CPV-2 antigen-containing vaccines released in part.

G10627

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Calefur Sterile Powder for Injection (62682).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10626

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Caleflunix Injection (63989).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10625

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Calesed Injection (63855).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10624

2 August 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Caledoxy 100 Tablets (62220).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10631

17 July 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 500 Broad Spectrum Antibiotic Tablets (61671).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10630

17 July 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 250 Broad Spectrum Antibiotic Tablets (61670).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10629

17 July 2013

Notice of registration, finished product specifications, approved shelf life and storage conditions for Juroclav 50 Broad Spectrum Antibiotic Tablets (61669).

Notice of Registration and Approval of Label Under the Agvet Codes released in part.

G10489

17 July 2013

Unfiltered data (copies of all adverse experience forms) lodged between 1 January and 31 December 2010 by veterinarians, pet owners and manufacturers, for CPV-2 antigen-containing vaccines administered to dogs of all ages.

Adverse experience reports submitted to the APVMA relating to CPV-2 antigen-containing vaccines released in part.

Contact details for freedom of information enquiries

Phone: +61 2 6210 4785
Fax: +61 2 6210 4787

See also: information about making a request

Email: foi@apvma.gov.au

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.